1. Home
  2. SSTI vs XBIT Comparison

SSTI vs XBIT Comparison

Compare SSTI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoundThinking Inc.

SSTI

SoundThinking Inc.

HOLD

Current Price

$6.71

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.36

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSTI
XBIT
Founded
1996
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
71.3M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
SSTI
XBIT
Price
$6.71
$2.36
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
166.6K
44.2K
Earning Date
03-03-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,753,000.00
N/A
Revenue This Year
$11.93
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.25
N/A
52 Week Low
$5.78
$2.09
52 Week High
$17.38
$3.62

Technical Indicators

Market Signals
Indicator
SSTI
XBIT
Relative Strength Index (RSI) 46.09 51.24
Support Level $6.03 $2.32
Resistance Level $7.96 $2.49
Average True Range (ATR) 0.49 0.10
MACD -0.04 0.01
Stochastic Oscillator 39.29 61.90

Price Performance

Historical Comparison
SSTI
XBIT

About SSTI SoundThinking Inc.

SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: